Condition: Metabolic Dysfunction-associated Steatohepatitis (MASH) · Sponsor: Kriya Therapeutics, Inc.
A Study of VV-14303 for the Treatment of Metabolic dysfunction-associated steatohepatitis (MASH)
This description comes directly from the study's public registry record.
VP, Medical Affairs · 1.984.884.5058 · clinicaltrials@kriyatx.com
Always discuss trial participation with your own doctor first.
| Kriya Clinical Trial Site | Chandler, Arizona, United States | — |
| Kriya Clinical Trial Site | Lady Lake, Florida, United States | — |
| Kriya Clinical Trial Site | Auckland, New Zealand | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07732400